About

Owen Marks, Omgen

Owen Marks is the Principal at OMGEN, a consultancy specialising in launch execution across specialty, rare disease and gene therapy. OMGEN also works with organisations on leadership and change management, DE&I initiatives, coaching and building high-performance cultures.

Before founding OMGEN, Owen was head of Rare Diseases at Pfizer UK and held a variety of international and global leadership roles. Beyond his corporate experience, he has chaired the Advanced Therapeutic Medicines Group for the ABPI and currently serves as a Non-Executive Director and Trustee for C3 – Collaborating for Health.